279 related articles for article (PubMed ID: 8941014)
21. Malignant epithelial tumors and hematologic malignancy.
Marković-Glamocak M; Sucić M; Ries S; Gjadrov-Kuvezdić K; Labar B
Diagn Cytopathol; 2008 Oct; 36(10):710-4. PubMed ID: 18773444
[TBL] [Abstract][Full Text] [Related]
22. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
23. The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors.
Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Einhorn L; Kanz L; Bokemeyer C
Cancer; 2000 Jun; 88(11):2629-35. PubMed ID: 10861442
[TBL] [Abstract][Full Text] [Related]
24. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
[TBL] [Abstract][Full Text] [Related]
25. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
26. Fine-needle aspiration cytology of papillary renal cell carcinoma: the association with concomitant secondary malignancies.
Lim JC; Wojcik EM
Diagn Cytopathol; 2006 Dec; 34(12):797-800. PubMed ID: 17115441
[TBL] [Abstract][Full Text] [Related]
27. [High incidence of non-AIDS-defined cancers among HIV-infected patients in Germany. A 3-year nationwide review].
Mosthaf FA; Hanhoff NJ; Goetzenich A; Wolf E; Knechten H
Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1849-52. PubMed ID: 16915544
[TBL] [Abstract][Full Text] [Related]
28. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
[TBL] [Abstract][Full Text] [Related]
29. Microtubule organization in lymphoid malignancies.
Hirose Y; Konda S
Blood Cells; 1992; 18(2):225-38; discussion 239-40. PubMed ID: 1450424
[TBL] [Abstract][Full Text] [Related]
30. Coccidioidomycosis in patients with hematologic malignancies.
Blair JE; Smilack JD; Caples SM
Arch Intern Med; 2005 Jan; 165(1):113-7. PubMed ID: 15642886
[TBL] [Abstract][Full Text] [Related]
31. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.
Beisland C; Talleraas O; Bakke A; Norstein J
BJU Int; 2006 Apr; 97(4):698-702. PubMed ID: 16536756
[TBL] [Abstract][Full Text] [Related]
32. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
33. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
[TBL] [Abstract][Full Text] [Related]
35. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
36. [Pathological anatomy of primary cerebral lymphoma].
Menet E; Goujon JM; Levillain P; Babin P
Neurochirurgie; 1997; 43(6):357-60. PubMed ID: 9706612
[TBL] [Abstract][Full Text] [Related]
37. [Non-Hodgkin's lymphoma, renal carcinoma, and meningioma. A clinical case].
Lolli E; Matteoni R; Barbieri A; D'Ambrosi M; Archontakis F
Ann Ital Chir; 1998; 69(1):101-4. PubMed ID: 11995031
[TBL] [Abstract][Full Text] [Related]
38. [Synchronous chromophobe renal carcinoma and centrocytic lymphoma].
Márquez Moreno AJ; Mañas Uxó J; Amores Ramírez F; Aguilar Cuevas R; Ortega Jiménez MV; Leiva Vera C; Pérez Rodríguez D
Arch Esp Urol; 2003 May; 56(4):415-7. PubMed ID: 12830613
[TBL] [Abstract][Full Text] [Related]
39. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
40. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.
Geier D; Hebert B; Potti A
Anticancer Res; 2002; 22(6B):3797-9. PubMed ID: 12552996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
